UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read moreFri, 06th Mar 2020 10:07
UK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: Diurnal Taps Investors For GBP9.8 Million
Read moreIN BRIEF: Diurnal's Swiss Partner Seeks Marketing Approval For Alkindi
Read more(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced on Wednesday that its marketing and distribution partner in Switzerland, EffRx Pharmaceuticals, has submitted a market authorisation application to Swissmedic for the registration of 'Alkindi', or hydrocortisone granules in capsules for opening, in the country.
Read more(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced a proposed conditional placing with institutional investors to raise up to £8m before expenses on Friday, at a price of 60p per share, and an open offer to raise up to a further £2m.
Read moreDiurnal Raises GBP8 Million For Product Development, Commercialisation
Read moreIN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle
Read moreIN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows
Read moreIN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts
Read more(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced two further European market and distribution agreements for its products 'Alkindi', or hydrocortisone granules in capsules for opening, and 'Chronocort', or modified release hydrocortisone, on Thursday.
Read moreIN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi
Read moreUK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half
Read moreClinigen Chair Leaves Audit Committee After Shareholder Engagement
Read more